The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

IMS is buyout bait?

 Oct 20, 2009 07:40 PM UTC
Return Risk
+0.00% N/A
Tracked Blogger
Symbol Sentiment Start Return Closed
RX n/a

Graphic_arrow1 Via BloggingStocks:  

Filed under: Private equity

Activity continues to buzz in the private equity world. For example, according to the Wall Street Journal (subscription required), it appears that IMS (NYSE: RX) is in advanced talks to take the company private. As a result, the shares of the company soared 22% in Monday's trading.


No doubt, a deal could fall apart. But, the fact remains that IMS has definitely attracted interest. Some of the suitors include: TPG, Silver Lake, and BC Partners. The deal could be worth as much as $3.5 billion.


IMS got its start in the mid 1950s when the founders -- Bill Frohlich (an advertising executive) and David Dubow -- saw an opportunity to build a unique information company for the pharma industry. The timing was perfect as the company quickly grew.

Continue reading IMS is buyout bait?

IMS is buyout bait? originally appeared on BloggingStocks on Tue, 20 Oct 2009 14:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati




 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch